
THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO,
For immediate release
Legal Entity Identifier: 213800CU1PIC7GAER820
TENDER OFFER, MIX AND MATCH FACILITY AND TREASURY ISSUANCE RESULTS
The Company is pleased to announce that 1,666,142 Shares were validly tendered under the Tender Offer and 170,811 Shares were applied for under the Mix and Match Facility.
Tenders will therefore be accepted in full from Shareholders who validly tendered their Basic Entitlement or any number of Shares less than their Basic Entitlement.
The 1,495,331 Shares validly tendered but not matched under the Mix and Match Facility will be purchased by
Under the terms of the Repurchase Agreement, these tendered Shares will be purchased by the Company from
As set out in the Circular, it is anticipated that the proceeds payable to Shareholders whose tendered Shares are held through CREST accounts will be made by
Balance certificates in respect of the Tender Offer and new certificates in respect of the Mix and Match Facility will be despatched in respect of certificated Shares during the week commencing
Total Voting Rights
Following the completion of the Tender Offer and the Mix and Match Facility, the Company will have a total of 45,549,975 Shares in issue of which 5,032,270 Shares are held in
Defined terms used in this announcement have the meanings given in the Circular unless the context otherwise requires
For further information please contact:
|
Tel: +44 (0) 141 306 7400 |
Company Secretary |
|
|
|
|
|
|
Tel: +44 (0) 20 7649 6933 |
Financial Adviser |
|
|
|
|
|
|
Tel: +44 (0) 20 7408 4050 |
Corporate Broker |
|
|
|
|
|
This announcement is released by the Company and the information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the